{"id":12933,"date":"2026-08-06T17:26:11","date_gmt":"2026-08-06T15:26:11","guid":{"rendered":"https:\/\/www.ipe-evaluation.de\/?post_type=use-case&#038;p=12933"},"modified":"2026-08-31T09:10:21","modified_gmt":"2026-08-31T07:10:21","slug":"budget-impact-analysis-bia","status":"publish","type":"use-case","link":"https:\/\/www.ipe-evaluation.de\/en\/use-case\/budget-impact-analysis-bia\/","title":{"rendered":"Budget Impact Analysis (BIA)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>We have modelled the multi-year budgetary implications for the funding bodies following the introduction of a medicinal product for atopic dermatitis.<\/p>","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true},"class_list":["post-12933","use-case","type-use-case","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ipe-evaluation.de\/en\/wp-json\/wp\/v2\/use-case\/12933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipe-evaluation.de\/en\/wp-json\/wp\/v2\/use-case"}],"about":[{"href":"https:\/\/www.ipe-evaluation.de\/en\/wp-json\/wp\/v2\/types\/use-case"}],"wp:attachment":[{"href":"https:\/\/www.ipe-evaluation.de\/en\/wp-json\/wp\/v2\/media?parent=12933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}